Alexandra Margeli

Summary

Affiliation: University of Athens
Country: Greece

Publications

  1. Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, et al. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. J Oral Pathol Med. 2011;40:706-14 pubmed publisher
    ....
  2. Giaginis C, Tsoukalas N, Bournakis E, Alexandrou P, Kavantzas N, Patsouris E, et al. Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival. BMC Clin Pathol. 2014;14:8 pubmed publisher
    ....
  3. Kotta Loizou I, Patsouris E, Theocharis S. Pregnane X receptor polymorphisms associated with human diseases. Expert Opin Ther Targets. 2013;17:1167-77 pubmed publisher
    ..PXR polymorphisms could be implicated in selective drug targeting leading to PXR modulation. Nevertheless, additional studies are required to fully understand their potential. ..
  4. Theocharis S, Margeli A, Koutselinis A. Metallothionein: a multifunctional protein from toxicity to cancer. Int J Biol Markers. 2003;18:162-9 pubmed
    ..In the present review the involvement of MT in defense mechanisms to toxicity and in carcinogenicity is discussed...
  5. Theocharis S, Klijanienko J, Padoy E, Athanassiou S, Sastre Garau X. Focal adhesion kinase (FAK) immunocytochemical expression in breast ductal invasive carcinoma (DIC): correlation with clinicopathological parameters and tumor proliferative capacity. Med Sci Monit. 2009;15:BR221-6 pubmed
    ..Further molecular and clinical studies are required to delineate the significance of FAK as a factor for better prognosis and management of breast cancer patients. ..
  6. Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, et al. Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival. J Oral Pathol Med. 2011;40:218-26 pubmed publisher
    ..0451). The present study supported evidence for possible implication of MSH2, MLH1 and MGMT proteins in the formation and progression of mobile tongue SCC. ..
  7. Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, et al. RCAS1 expression in mobile tongue squamous cell carcinoma: an immunohistochemical study. Med Sci Monit. 2011;17:BR228-234 pubmed
    ....
  8. Theocharis S, Klijanienko J, Giaginis C, Alexandrou P, Patsouris E, Sastre Garau X. FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. J Cancer Res Clin Oncol. 2012;138:1369-77 pubmed publisher
    ..The present study supported evidence for a potential role of FAK and Src signaling in mobile tongue SCC, rendering their small-molecule tyrosine kinase inhibitors as possible treatment strategy in tongue cancer chemoprevention. ..

Locale

Collaborators

Detail Information

Publications8

  1. Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, et al. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. J Oral Pathol Med. 2011;40:706-14 pubmed publisher
    ....
  2. Giaginis C, Tsoukalas N, Bournakis E, Alexandrou P, Kavantzas N, Patsouris E, et al. Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival. BMC Clin Pathol. 2014;14:8 pubmed publisher
    ....
  3. Kotta Loizou I, Patsouris E, Theocharis S. Pregnane X receptor polymorphisms associated with human diseases. Expert Opin Ther Targets. 2013;17:1167-77 pubmed publisher
    ..PXR polymorphisms could be implicated in selective drug targeting leading to PXR modulation. Nevertheless, additional studies are required to fully understand their potential. ..
  4. Theocharis S, Margeli A, Koutselinis A. Metallothionein: a multifunctional protein from toxicity to cancer. Int J Biol Markers. 2003;18:162-9 pubmed
    ..In the present review the involvement of MT in defense mechanisms to toxicity and in carcinogenicity is discussed...
  5. Theocharis S, Klijanienko J, Padoy E, Athanassiou S, Sastre Garau X. Focal adhesion kinase (FAK) immunocytochemical expression in breast ductal invasive carcinoma (DIC): correlation with clinicopathological parameters and tumor proliferative capacity. Med Sci Monit. 2009;15:BR221-6 pubmed
    ..Further molecular and clinical studies are required to delineate the significance of FAK as a factor for better prognosis and management of breast cancer patients. ..
  6. Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, et al. Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival. J Oral Pathol Med. 2011;40:218-26 pubmed publisher
    ..0451). The present study supported evidence for possible implication of MSH2, MLH1 and MGMT proteins in the formation and progression of mobile tongue SCC. ..
  7. Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A, et al. RCAS1 expression in mobile tongue squamous cell carcinoma: an immunohistochemical study. Med Sci Monit. 2011;17:BR228-234 pubmed
    ....
  8. Theocharis S, Klijanienko J, Giaginis C, Alexandrou P, Patsouris E, Sastre Garau X. FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. J Cancer Res Clin Oncol. 2012;138:1369-77 pubmed publisher
    ..The present study supported evidence for a potential role of FAK and Src signaling in mobile tongue SCC, rendering their small-molecule tyrosine kinase inhibitors as possible treatment strategy in tongue cancer chemoprevention. ..